Combination Treatment with Low-dose Niaspan and Tissue Plasminogen Activator Provides Neuroprotection after Embolic Stroke in Rats

INTRODUCTION: Niaspan, an extended-release formulation of Niacin (vitamin B3), has been widely used to increase high density lipoprotein (HDL) cholesterol and to prevent cardiovascular diseases and stroke. We have previously demonstrated that Niaspan (40mg/kg) administered at 2 hours after stroke in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Shehadah, Amjad, Chen, Jieli, Cui, Yisheng, Zhang, Li, Roberts, Cynthia, Lu, Mei, Chopp, Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166443/
https://ncbi.nlm.nih.gov/pubmed/21802695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2011.07.008
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak